Last update June 14, 2022

Aripiprazole

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

It is an atypical antipsychotic used in the treatment of schizophrenia, bipolar disorder, major depressive disorder, irritability associated with autism and Tourette syndrome. Oral (or intramuscular) administration once daily.

Its pharmacokinetic data (low oral bioavailability, large volume of distribution, moderately elevated molecular weight and high plasma protein binding) explains the negligible or zero passage into breast milk observed. (Nordeng 2014, Watanabe 2011, Lutz 2010, Schlotterbeck 2007)

No problems were observed in infants whose mothers were taking it (Nordeng 2014, Tarikh 2014, Lutz 2010). The plasma levels of these infants were undetectable or very low. (Watanabe 2011)

Its relationship with prolactin is controversial because it lowers prolactin levels and has been used to treat prolactinomas and hyperprolactinemia induced by the use of other antipsychotics ( Propst 2016, Bakker 2016, Ranjbar 2015, Raghuthaman 2015, Safer 2013, Byerly 2009, Wolf 2007, Lorenz 2007, Goodnick 2002) and several cases of decreased milk production have been reported (Komaroff 2021, Walker 2019, Yskes 2018, Morin 2017, Frew 2015, Mendhekar 2006), although there are also cases of hyperprolactinemia-galactorrhea triggered by aripiprazole. (Gunes 2018, Sogawa 2016, Prost 2016, Saraf 2014, Mendhekar 2005, Ruffatti 2005)

Expert authors consider the use of this medication possible during breastfeeding (Hale, Cuomo 2018, Larsen 2015, Parikh 2014). Monitor for possible drowsiness in the infant. (Hale 2017 p.74)

Due to its slow elimination and the risk of affecting milk production, it may be worthwhile using other compatible antipsychotics with a shorter half-life, especially during the neonatal period and in case of prematurity. (Uguz 2021 & 2016)


See below the information of this related product:

Alternatives

  • Haloperidol (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Olanzapine (Safe product and/or breastfeeding is the best option.)
  • Quetiapine Fumarate (Safe product and/or breastfeeding is the best option.)
  • Risperidone (Safe product and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Aripiprazole in other languages or writings:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 87 %
Molecular weight 448 daltons
Protein Binding 99 %
VD 5 l/Kg
pKa 13.5 -
Tmax 3 - 5 hours
75 - 95 hours
M/P ratio 0.04 -
Theoretical Dose 0.002 - 0.008 mg/Kg/d
Relative Dose 0.7 - 4.8 %

References

  1. Komaroff A. Aripiprazole and lactation failure: The importance of shared decision making. A case report. Case Rep Womens Health. 2021 Mar 13;30:e00308. Abstract
  2. Uguz F. A New Safety Scoring System for the Use of Psychotropic Drugs During Lactation. Am J Ther. 2021 Jan-Feb 01;28(1):e118-e126. Abstract
  3. Walker T, Coursey C, Duffus ALJ. Low dose of Abilify (aripiprazole) in combination with Effexor XR (venlafaxine HCl) resulted in cessation of lactation. Clin Lact (Amarillo). 2019;10:56–9. Abstract
  4. Gunes S. Hyperprolactinemic Galactorrhea as a Side Effect of Aripiprazole: An Adolescent Case (Aripiprazole-Related Hyperprolactinemic Galactorrhea). J Clin Psychopharmacol. 2018 Abstract
  5. Yskes R, Thomas R, Nagalla ML. A Case of Decreased Milk Production Associated With Aripiprazole. Prim Care Companion CNS Disord. 2018 Nov 29;20(6). pii: 18l02303. Abstract
  6. Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Disord. 2018 Mar 1;228:229-237. Abstract
  7. Hale TW, Rowe HE. Medications & Mothers' Milk. A Manual of Lactation Pharmacology. Springer Publishing Company. 2017
  8. Morin C, Chevalier I. Severe Hypernatremic Dehydration and Lower Limb Gangrene in an Infant Exposed to Lamotrigine, Aripiprazole, and Sertraline in Breast Milk. Breastfeed Med. 2017 Abstract
  9. Sogawa R, Shimomura Y, Minami C, Maruo J, Kunitake Y, Mizoguchi Y, Kawashima T, Monji A, Hara H. Aripiprazole-Associated Hypoprolactinemia in the Clinical Setting. J Clin Psychopharmacol. 2016 Abstract
  10. Propst AJ, Jarvis GE, Margolese HC. Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis. Clin Schizophr Relat Psychoses. 2016 Abstract
  11. Uguz F. Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety. Am J Ther. 2016;36(3):244-52. Abstract
  12. Bakker IC, Schubart CD, Zelissen PM. Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole. Endocrinol Diabetes Metab Case Rep. 2016 Abstract Full text (link to original source)
  13. Raghuthaman G, Venkateswaran R, Krishnadas R. Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial. BJPsych Open. 2015 Abstract Full text (link to original source)
  14. Ranjbar F, Sadeghi-Bazargani H, Niari Khams P, Arfaie A, Salari A, Farahbakhsh M. Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia. Neuropsychiatr Dis Treat. 2015 Abstract Full text (link to original source)
  15. Frew JR. Psychopharmacology of bipolar I disorder during lactation: a case report of the use of lithium and aripiprazole in a nursing mother. Arch Womens Ment Health. 2015 Abstract
  16. Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen RE, Linde VJ, Knudsen HE, Skaarup L, Videbech P. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand Suppl. 2015 Abstract
  17. Parikh T, Goyal D, Scarff JR, Lippmann S. Antipsychotic drugs and safety concerns for breast-feeding infants. South Med J. 2014 Abstract
  18. Saraf G, Behere RV, Venkatasubramanian G, Rao NP, Varambally S, Gangadhar BN. Hyperprolactinemia with aripiprazole: understanding the paradox. Am J Ther. 2014 Abstract
  19. Nordeng H, Gjerdalen G, Brede WR, Michelsen LS, Spigset O. Transfer of aripiprazole to breast milk: a case report. J Clin Psychopharmacol. 2014 Apr;34(2):272-5. Abstract
  20. Safer DJ, Calarge CA, Safer AM. Prolactin serum concentrations during aripiprazole treatment in youth. J Child Adolesc Psychopharmacol. 2013 Abstract Full text (link to original source)
  21. Watanabe N, Kasahara M, Sugibayashi R, Nakamura T, Nakajima K, Watanabe O, Murashima A. Perinatal use of aripiprazole: a case report. J Clin Psychopharmacol. 2011 Abstract
  22. Lutz UC, Hiemke C, Wiatr G, Farger G, Arand J, Wildgruber D. Aripiprazole in pregnancy and lactation: a case report. J Clin Psychopharmacol. 2010 Abstract
  23. Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res. 2009 Abstract
  24. Lorenz RA, Weinstein B. Resolution of haloperidol-induced hyperprolactinemia with aripiprazole. J Clin Psychopharmacol. 2007 Abstract
  25. Wolf J, Fiedler U. Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole. J Clin Pharm Ther. 2007 Abstract
  26. Schlotterbeck P, Leube D, Kircher T, Hiemke C, Gründer G. Aripiprazole in human milk. Int J Neuropsychopharmacol. 2007 Abstract Full text (in our servers)
  27. Mendhekar DN, Sunder KR, Andrade C. Aripiprazole use in a pregnant schizoaffective woman. Bipolar Disord. 2006 Abstract
  28. Ruffatti A, Minervini L, Romano M, Sonino N. Galactorrhea with aripiprazole. Psychother Psychosom. 2005 Abstract
  29. Mendhekar DN, Andrade C. Galactorrhea with aripiprazole. Can J Psychiatry. 2005 Abstract
  30. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother. 2002 Oct;3(10):1381-91. Review. Abstract

Total visits

38,292

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM